| abstract |
The present invention provides compounds of formula (I) or stereoisomers, tautomers or pharmaceutically acceptable salts thereof, wherein all variables thereof are as defined in the specification. These compounds are selective factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. The invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic disorders and / or inflammatory disorders using said compounds. |